Expert Review of Precision Medicine and Drug Development
Now an Open Access Journal
Submit Your ResearchExpert Review of Precision Medicine and Drug Development is converting to Open Access
Expert Review of Precision Medicine and Drug Development is an international journal publishing rigorously peer-reviewed review articles and original papers on the development and clinical application of medicine to be used in a personalised therapy setting.
In an era where medicine is recognizing that a one-size-fits-all approach is not always appropriate, Expert Review of Precision Medicine and Drug Development supports the necessity to identify patients responsive to treatments and treat patient populations using a tailored approach.
We have listened to the needs of the research community in this area and that is why we’re pleased to announce the journal has moved to an Open Access model. By making Expert Review of Precision Medicine and Drug Development open access, research published in the journal will be available to the widest possible audience and therefore can make a greater contribution to the medicine and drug development research community. All manuscripts submitted to the journal will, if accepted, be required to pay an article publishing charge (APC) which can be covered by an author’s funder or institution. We look forward to receiving your submissions and welcome your support in this exciting new open access chapter for the journal. Use the Open Access cost finder to find information on APC fees.
Articles in Expert Review of Precision Medicine and Drug Development focus on the following key areas:
Development and application of drugs targeted to specific genotypes and populations, as well as advanced diagnostic technologies and significant biomarkers that aid in this;
Clinical trials and case studies within personalised therapy and drug development;
Screening, prediction and prevention of disease, prediction of adverse events, treatment monitoring, effects of metabolomics and microbiomics on treatment;
Secondary population research, genome-wide association studies, disease–gene association studies, personal genome technologies;
Ethical and cost–benefit issues, the impact to healthcare and business infrastructure, and regulatory issues.
Why publish open access?
Increase the visibility and readership of your research by publishing in a fully open access journal.
Make an impact beyond the academy by making your article accessible to anyone, anywhere (including readers in industry and even policy-makers).
Freely share your work with no restrictions or paywall.
Retain ownership of your research through our unrestrictive publishing agreements.
Discounts and waivers for researchers in developing countries are available. The journal will also consider requests for discretionary APC waivers. Find out if your institution or country has an open access agreement to publish with us.
Expert Review of Precision Medicine and Drug Development is particularly interested in receiving manuscripts on:
Novel delivery technologies, nanocarriers, vehicles, devices, and formulations
Controlled drug-delivery systems in different indications
Different modes of entry into the body
Various release mechanisms
